Mechanism of action
Urea exerts its therapeutic effects through multiple mechanisms. As a keratolytic agent, it penetrates the stratum corneum and disrupts hydrogen bonds within the keratin structure, dissolving the intracellular matrix that holds corneocytes together. This action promotes desquamation of hyperkeratotic and scaling skin.
As a humectant, urea is highly hygroscopic and attracts water molecules from the dermis and environment into the stratum corneum, increasing skin hydration by up to 80%. At concentrations above 10%, urea also denatures proteins, which contributes to its keratolytic properties.
At higher concentrations (30-40%), urea can penetrate the nail plate and soften dystrophic nails. It also enhances penetration of other topical agents by increasing the permeability of the stratum corneum, making it a useful vehicle component in combination products.
Urea has mild antimicrobial properties and can reduce pruritus through its hydrating effects, though it is not considered a primary antipruritic agent.
- Urea acts as both a keratolytic (breaks down keratin) and humectant (attracts water to skin)
- Concentration-dependent effects: 10-20% primarily hydrates; 30-40% provides keratolytic action
- Most common side effect is stinging/burning, especially on inflamed or fissured skin
- Enhances penetration of other topical medications by increasing stratum corneum permeability
- Safe in pregnancy (Category B) due to minimal systemic absorption
- Used for xerosis, ichthyosis, psoriasis, hyperkeratosis, and nail dystrophy
- 40% urea under occlusion softens dystrophic nails before debridement or antifungal therapy
- Dissolves intercellular matrix of stratum corneum by disrupting hydrogen bonds in keratin
Indications
Urea is indicated for a range of dermatologic conditions characterized by dryness, scaling, and hyperkeratosis:
- Xerosis (dry skin) and generalized ichthyosis
- Psoriasis and atopic dermatitis (as adjunctive therapy for scaling and hydration)
- Keratosis pilaris and other follicular keratotic disorders
- Palmoplantar keratoderma and plantar calluses
- Onychomycosis (as adjunctive nail preparation before antifungal therapy)
- Nail dystrophy and thickened nails
- Eczema with significant xerosis
- Seborrheic dermatitis of the scalp
Urea is also used off-label to enhance penetration of corticosteroids and other topical medications in hyperkeratotic conditions. Concentration selection depends on indication: 10-20% for mild to moderate xerosis, 30-40% for significant hyperkeratosis or nail disorders.
Pharmacokinetics
Urea is applied topically and absorption through intact skin is minimal. When applied to diseased or disrupted skin, systemic absorption may increase slightly but remains clinically insignificant.
Absorption: Minimal systemic absorption occurs through intact stratum corneum; increased absorption through inflamed, eroded, or hyperkeratotic skin does not typically result in measurable plasma levels.
Distribution: Urea acts locally at the site of application. Any absorbed urea enters systemic circulation but is indistinguishable from endogenous urea.
Metabolism: Systemically absorbed urea is handled by normal physiologic pathways. Endogenous urea is synthesized in the liver as the end product of protein metabolism and is the primary vehicle for nitrogen excretion.
Excretion: Any absorbed exogenous urea is filtered by the kidneys and excreted in urine, similar to endogenous urea. The elimination half-life of endogenous urea is negligible for topical applications.
Urea-containing products are typically applied once or twice daily. Occlusion can enhance penetration and efficacy.
Adverse effects
Urea is generally well tolerated, with most adverse effects being mild and localized to the application site.
Common adverse effects
- Stinging and burning sensation (most common, especially on inflamed or fissured skin)
- Transient erythema at application site
- Pruritus or worsening of itching in some patients
- Local irritation and contact dermatitis
Less common adverse effects
- Skin maceration with prolonged occlusive use
- Hypersensitivity reactions (rare)
- Exacerbation of inflammation if applied to acutely inflamed skin
The burning sensation is concentration-dependent and typically diminishes with continued use. To minimize irritation, urea should be applied to intact or healing skin rather than open wounds or acutely inflamed areas. Starting with lower concentrations (10-20%) and titrating upward can improve tolerance.
Systemic toxicity from topical urea is not reported due to minimal absorption and the body's efficient handling of urea through normal renal excretion.
Contraindications and warnings
Contraindications
- Hypersensitivity to urea or any component of the formulation
- Application to open wounds, acutely inflamed skin, or mucosal surfaces (relative contraindication; may cause severe burning)
Warnings and precautions
- Avoid contact with eyes and mucous membranes: Flush with water if accidental exposure occurs
- Use caution on broken or inflamed skin: May cause significant stinging or worsen inflammation
- Renal impairment: Not a concern for topical use, as systemic absorption is negligible; however, theoretical accumulation could occur with extensive application over large body surface areas in severe renal failure
- Pediatric use: Generally safe in children; use lower concentrations (10-20%) to minimize irritation
- Pregnancy: Classified as Pregnancy Category B (animal studies show no risk; adequate human studies lacking); considered safe for topical use during pregnancy and lactation due to minimal systemic absorption
Application precautions
- For external use only
- Discontinue use if excessive irritation or sensitization occurs
- Avoid occlusive dressings over large body surface areas with high-concentration formulations
Drug interactions
Urea has minimal systemic absorption and no clinically significant systemic drug interactions.
Topical interactions
- Enhances penetration of other topical agents: Urea increases stratum corneum permeability, potentially increasing absorption and efficacy (or toxicity) of co-applied topical medications such as corticosteroids, retinoids, or topical chemotherapy agents
- Topical corticosteroids: Co-administration may enhance corticosteroid penetration and therapeutic effect; monitor for increased local or systemic corticosteroid effects if large surface areas are treated
- Salicylic acid and other keratolytics: Additive keratolytic effects may increase irritation; use combination products as directed
- Topical retinoids: May increase irritation when used concurrently; consider applying at different times of day
No dose adjustments are required based on systemic medications. Urea does not affect cytochrome P450 enzymes or renal drug clearance.
Clinical pearls
- Concentration matters: 10-20% urea is primarily humectant; 30-40% urea provides significant keratolytic action for hyperkeratosis and nail dystrophy
- Burning sensation is common but usually improves with continued use; applying to slightly damp skin or using lower concentrations initially can improve tolerance
- Excellent adjunct therapy: Urea enhances efficacy of topical corticosteroids in psoriasis and eczema by improving penetration and reducing scale
- Nail preparation: 40% urea under occlusion for 7-14 days can soften dystrophic nails before mechanical debridement or facilitate antifungal penetration in onychomycosis
- Safe in pregnancy and children: Minimal systemic absorption makes urea one of the safest keratolytics for vulnerable populations
- Apply to damp skin: Applying urea-containing products immediately after bathing maximizes hydration and humectant effects
- Avoid acutely inflamed skin: Wait until acute inflammation subsides to minimize burning and irritation
- Cost-effective: Generic urea formulations are inexpensive and effective alternatives to branded emollients for chronic xerosis
- Not a primary treatment for infection: While urea has mild antimicrobial properties, it should not replace antifungal or antibacterial therapy in infected conditions
- Monitor for overhydration: Excessive occlusion with high-concentration urea can cause maceration; use cautiously in intertriginous areas
Practice questions
1. A 45-year-old woman with a history of atopic dermatitis presents with severely dry, scaly skin on her legs that has not improved with standard emollients. You prescribe 20% urea cream to be applied twice daily. Three days later, she calls reporting significant burning and stinging when applying the cream. Physical examination shows erythematous, fissured skin with lichenification. What is the most appropriate next step?
2. A 62-year-old man with type 2 diabetes and chronic kidney disease (eGFR 25 mL/min/1.73m²) presents with thickened, discolored toenails consistent with onychomycosis. His dermatologist recommends applying 40% urea cream under occlusion nightly for 2 weeks to soften the nails before starting oral antifungal therapy. The patient is concerned about his kidney disease. What is the most accurate statement regarding topical urea use in this patient?
3. A 28-year-old woman with plaque psoriasis is prescribed betamethasone dipropionate 0.05% ointment for lesions on her elbows and knees. Her dermatologist also recommends adding 20% urea cream to the regimen. What is the primary rationale for adding urea to her treatment?
Frequently asked questions
How does urea work on the skin?
Urea works through two main mechanisms: as a keratolytic agent, it breaks down the intercellular matrix of the stratum corneum by disrupting hydrogen bonds in keratin proteins, promoting desquamation of dead skin cells; and as a humectant, it attracts and retains water in the skin, increasing hydration by up to 80%. At concentrations above 30%, urea also denatures proteins, providing significant keratolytic effects useful for hyperkeratotic conditions and thickened nails.
What are the side effects of urea cream?
The most common side effect of urea cream is a stinging or burning sensation at the application site, particularly when applied to inflamed, fissured, or broken skin. Other side effects include transient redness, local irritation, itching, and rarely contact dermatitis. These effects are usually mild and diminish with continued use. The burning sensation is concentration-dependent, and starting with lower concentrations (10-20%) can improve tolerance. Systemic side effects do not occur due to minimal absorption through intact skin.
What is urea cream used for?
Urea cream is used to treat dry skin (xerosis), ichthyosis, psoriasis, keratosis pilaris, eczema with significant dryness, palmoplantar keratoderma, calluses, and nail dystrophy. At lower concentrations (10-20%), it primarily hydrates and softens skin. At higher concentrations (30-40%), it provides keratolytic action to remove thick, scaly skin and can soften dystrophic or thickened nails. Urea is also used as an adjunct to enhance penetration of other topical medications like corticosteroids in hyperkeratotic skin conditions.
Is urea safe during pregnancy?
Yes, topical urea is considered safe during pregnancy and is classified as Pregnancy Category B. Animal reproduction studies have shown no fetal risk, and although adequate human studies are lacking, the minimal systemic absorption of topical urea makes it one of the safest keratolytic and emollient options for pregnant women. It is also considered safe during breastfeeding due to negligible systemic levels and local site of action.
What is the difference between urea cream and regular moisturizer?
Urea cream differs from regular moisturizers because it provides both keratolytic (exfoliating) and humectant (water-attracting) properties, whereas most regular moisturizers primarily work by creating an occlusive barrier to prevent water loss. Urea actively breaks down the protein matrix holding dead skin cells together, promoting desquamation while simultaneously drawing water into the skin layers. This dual action makes urea particularly effective for conditions with scaling and hyperkeratosis, not just simple dryness. Regular moisturizers containing petrolatum or dimethicone do not exfoliate or actively hydrate in the same way.
Conditions it is used for
Related drugs
Sources and further reading
DailyMed (FDA labels)StatPearls (NCBI Bookshelf)MedlinePlusWHO ATC/DDD index: D02AE01
Educational content for medical students, prepared by the WhiteCoat Pro editorial team with AI assistance; every page is reviewed by a second AI model for factual errors. It is not medical advice and does not replace the product label, local guidelines or a clinician.